9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-4-(2-methyl-3-methylidenecyclopenten-1-yl)-1-oxa-4,9-diazaspiro[5.5]undecan-5-one;9-[2-hydroxy-2-[2-methyl-4-(tetrazol-1-yl)phenyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one;9-[2-hydroxy-2-[6-(tetrazol-1-yl)pyridazin-3-yl]ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[2-hydroxy-2-[5-(tetrazol-1-yl)-2-pyridinyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one

C124H157N25O15 — CID 158348185

IUPAC9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-4-(2-methyl-3-methylidenecyclopenten-1-yl)-1-oxa-4,9-diazaspiro[5.5]undecan-5-one;9-[2-hydroxy-2-[2-methyl-4-(tetrazol-1-yl)phenyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one;9-[2-hydroxy-2-[6-(tetrazol-1-yl)pyridazin-3-yl]ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[2-hydroxy-2-[5-(tetrazol-1-yl)-2-pyridinyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one
SMILESC=C1C=C(N2CCCC3(CCN(CC(O)c4ccc(-n5cnnn5)cc4C)CC3)C2=O)CC1.C=C1C=C(N2CCCC3(CCN(CC(O)c4ccc(-n5cnnn5)cn4)CC3)C2=O)CC1.C=C1CCC(N2CCC3(CCCN(CC(O)c4ccc(-n5cnnn5)nn4)CC3)C2=O)=C1C.C=C1CCC(N2CCC3(CCCN(C[C@H](O)c4ccc5c(c4C)COC5=O)CC3)C2=O)=C1C.C=C1CCC(N2CCOC3(CCN(C[C@H](O)c4ccc5c(c4C)COC5=O)CC3)C2=O)=C1C
InChIInChI=1S/C27H34N2O4.C26H32N2O5.C25H32N6O2.C23H30N8O2.C23H29N7O2/c1-17-5-8-23(18(17)2)29-14-11-27(26(29)32)9-4-12-28(13-10-27)15-24(30)20-6-7-21-22(19(20)3)16-33-25(21)31;1-16-4-7-22(17(16)2)28-12-13-33-26(25(28)31)8-10-27(11-9-26)14-23(29)19-5-6-20-21(18(19)3)15-32-24(20)30;1-18-4-5-20(14-18)30-11-3-8-25(24(30)33)9-12-29(13-10-25)16-23(32)22-7-6-21(15-19(22)2)31-17-26-27-28-31;1-16-4-6-19(17(16)2)30-13-10-23(22(30)33)8-3-11-29(12-9-23)14-20(32)18-5-7-21(26-25-18)31-15-24-27-28-31;1-17-3-4-18(13-17)29-10-2-7-23(22(29)32)8-11-28(12-9-23)15-21(31)20-6-5-19(14-24-20)30-16-25-26-27-30/h6-7,24,30H,1,4-5,8-16H2,2-3H3;5-6,23,29H,1,4,7-15H2,2-3H3;6-7,14-15,17,23,32H,1,3-5,8-13,16H2,2H3;5,7,15,20,32H,1,3-4,6,8-14H2,2H3;5-6,13-14,16,21,31H,1-4,7-12,15H2/t24-,27?;23-;;;/m00.../s1
InChIKeyGRZKHTUJNYUQBB-CXHFQBSHSA-N
MW2237.78 g/mol
LogP13.83
Rot. Bonds23

About 9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-4-(2-methyl-3-methylidenecyclopenten-1-yl)-1-oxa-4,9-diazaspiro[5.5]undecan-5-one;9-[2-hydroxy-2-[2-methyl-4-(tetrazol-1-yl)phenyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one;9-[2-hydroxy-2-[6-(tetrazol-1-yl)pyridazin-3-yl]ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[2-hydroxy-2-[5-(tetrazol-1-yl)-2-pyridinyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one

9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-4-(2-methyl-3-methylidenecyclopenten-1-yl)-1-oxa-4,9-diazaspiro[5.5]undecan-5-one;9-[2-hydroxy-2-[2-methyl-4-(tetrazol-1-yl)phenyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one;9-[2-hydroxy-2-[6-(tetrazol-1-yl)pyridazin-3-yl]ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[2-hydroxy-2-[5-(tetrazol-1-yl)-2-pyridinyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one (PubChem CID 158348185) has the molecular formula C124H157N25O15 and a molecular weight of 2237.78 g/mol. Its IUPAC name is 9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-4-(2-methyl-3-methylidenecyclopenten-1-yl)-1-oxa-4,9-diazaspiro[5.5]undecan-5-one;9-[2-hydroxy-2-[2-methyl-4-(tetrazol-1-yl)phenyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one;9-[2-hydroxy-2-[6-(tetrazol-1-yl)pyridazin-3-yl]ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[2-hydroxy-2-[5-(tetrazol-1-yl)-2-pyridinyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one.

Molecular Properties

Compound Name9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-4-(2-methyl-3-methylidenecyclopenten-1-yl)-1-oxa-4,9-diazaspiro[5.5]undecan-5-one;9-[2-hydroxy-2-[2-methyl-4-(tetrazol-1-yl)phenyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one;9-[2-hydroxy-2-[6-(tetrazol-1-yl)pyridazin-3-yl]ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[2-hydroxy-2-[5-(tetrazol-1-yl)-2-pyridinyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one
PubChem CID158348185
Molecular FormulaC124H157N25O15
Molecular Weight2237.78 g/mol
Exact Mass2236.23
IUPAC Name9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-4-(2-methyl-3-methylidenecyclopenten-1-yl)-1-oxa-4,9-diazaspiro[5.5]undecan-5-one;9-[2-hydroxy-2-[2-methyl-4-(tetrazol-1-yl)phenyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one;9-[2-hydroxy-2-[6-(tetrazol-1-yl)pyridazin-3-yl]ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[2-hydroxy-2-[5-(tetrazol-1-yl)-2-pyridinyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one
SMILESC=C1C=C(N2CCCC3(CCN(CC(O)c4ccc(-n5cnnn5)cc4C)CC3)C2=O)CC1.C=C1C=C(N2CCCC3(CCN(CC(O)c4ccc(-n5cnnn5)cn4)CC3)C2=O)CC1.C=C1CCC(N2CCC3(CCCN(CC(O)c4ccc(-n5cnnn5)nn4)CC3)C2=O)=C1C.C=C1CCC(N2CCC3(CCCN(C[C@H](O)c4ccc5c(c4C)COC5=O)CC3)C2=O)=C1C.C=C1CCC(N2CCOC3(CCN(C[C@H](O)c4ccc5c(c4C)COC5=O)CC3)C2=O)=C1C
InChIInChI=1S/C27H34N2O4.C26H32N2O5.C25H32N6O2.C23H30N8O2.C23H29N7O2/c1-17-5-8-23(18(17)2)29-14-11-27(26(29)32)9-4-12-28(13-10-27)15-24(30)20-6-7-21-22(19(20)3)16-33-25(21)31;1-16-4-7-22(17(16)2)28-12-13-33-26(25(28)31)8-10-27(11-9-26)14-23(29)19-5-6-20-21(18(19)3)15-32-24(20)30;1-18-4-5-20(14-18)30-11-3-8-25(24(30)33)9-12-29(13-10-25)16-23(32)22-7-6-21(15-19(22)2)31-17-26-27-28-31;1-16-4-6-19(17(16)2)30-13-10-23(22(30)33)8-3-11-29(12-9-23)14-20(32)18-5-7-21(26-25-18)31-15-24-27-28-31;1-17-3-4-18(13-17)29-10-2-7-23(22(29)32)8-11-28(12-9-23)15-21(31)20-6-5-19(14-24-20)30-16-25-26-27-30/h6-7,24,30H,1,4-5,8-16H2,2-3H3;5-6,23,29H,1,4,7-15H2,2-3H3;6-7,14-15,17,23,32H,1,3-5,8-13,16H2,2H3;5,7,15,20,32H,1,3-4,6,8-14H2,2H3;5-6,13-14,16,21,31H,1-4,7-12,15H2/t24-,27?;23-;;;/m00.../s1
InChIKeyGRZKHTUJNYUQBB-CXHFQBSHSA-N
XLogP13.83
TPSA450.20 Ų
H-Bond Donors5
H-Bond Acceptors35
Rotatable Bonds23
Heavy Atoms164
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002237.78
LogP ≤ 513.83
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1035

Analyze 9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-4-(2-methyl-3-methylidenecyclopenten-1-yl)-1-oxa-4,9-diazaspiro[5.5]undecan-5-one;9-[2-hydroxy-2-[2-methyl-4-(tetrazol-1-yl)phenyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one;9-[2-hydroxy-2-[6-(tetrazol-1-yl)pyridazin-3-yl]ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[2-hydroxy-2-[5-(tetrazol-1-yl)-2-pyridinyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-4-(2-methyl-3-methylidenecyclopenten-1-yl)-1-oxa-4,9-diazaspiro[5.5]undecan-5-one;9-[2-hydroxy-2-[2-methyl-4-(tetrazol-1-yl)phenyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one;9-[2-hydroxy-2-[6-(tetrazol-1-yl)pyridazin-3-yl]ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[2-hydroxy-2-[5-(tetrazol-1-yl)-2-pyridinyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one?
The IUPAC name of 9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-4-(2-methyl-3-methylidenecyclopenten-1-yl)-1-oxa-4,9-diazaspiro[5.5]undecan-5-one;9-[2-hydroxy-2-[2-methyl-4-(tetrazol-1-yl)phenyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one;9-[2-hydroxy-2-[6-(tetrazol-1-yl)pyridazin-3-yl]ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[2-hydroxy-2-[5-(tetrazol-1-yl)-2-pyridinyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one (CID 158348185) is 9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-4-(2-methyl-3-methylidenecyclopenten-1-yl)-1-oxa-4,9-diazaspiro[5.5]undecan-5-one;9-[2-hydroxy-2-[2-methyl-4-(tetrazol-1-yl)phenyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one;9-[2-hydroxy-2-[6-(tetrazol-1-yl)pyridazin-3-yl]ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[2-hydroxy-2-[5-(tetrazol-1-yl)-2-pyridinyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one.
What is the SMILES notation for 9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-4-(2-methyl-3-methylidenecyclopenten-1-yl)-1-oxa-4,9-diazaspiro[5.5]undecan-5-one;9-[2-hydroxy-2-[2-methyl-4-(tetrazol-1-yl)phenyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one;9-[2-hydroxy-2-[6-(tetrazol-1-yl)pyridazin-3-yl]ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[2-hydroxy-2-[5-(tetrazol-1-yl)-2-pyridinyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one?
The canonical SMILES for 9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-4-(2-methyl-3-methylidenecyclopenten-1-yl)-1-oxa-4,9-diazaspiro[5.5]undecan-5-one;9-[2-hydroxy-2-[2-methyl-4-(tetrazol-1-yl)phenyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one;9-[2-hydroxy-2-[6-(tetrazol-1-yl)pyridazin-3-yl]ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[2-hydroxy-2-[5-(tetrazol-1-yl)-2-pyridinyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one is C=C1C=C(N2CCCC3(CCN(CC(O)c4ccc(-n5cnnn5)cc4C)CC3)C2=O)CC1.C=C1C=C(N2CCCC3(CCN(CC(O)c4ccc(-n5cnnn5)cn4)CC3)C2=O)CC1.C=C1CCC(N2CCC3(CCCN(CC(O)c4ccc(-n5cnnn5)nn4)CC3)C2=O)=C1C.C=C1CCC(N2CCC3(CCCN(C[C@H](O)c4ccc5c(c4C)COC5=O)CC3)C2=O)=C1C.C=C1CCC(N2CCOC3(CCN(C[C@H](O)c4ccc5c(c4C)COC5=O)CC3)C2=O)=C1C.
What is the InChIKey of 9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-4-(2-methyl-3-methylidenecyclopenten-1-yl)-1-oxa-4,9-diazaspiro[5.5]undecan-5-one;9-[2-hydroxy-2-[2-methyl-4-(tetrazol-1-yl)phenyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one;9-[2-hydroxy-2-[6-(tetrazol-1-yl)pyridazin-3-yl]ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[2-hydroxy-2-[5-(tetrazol-1-yl)-2-pyridinyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one?
The InChIKey is GRZKHTUJNYUQBB-CXHFQBSHSA-N. The full InChI is InChI=1S/C27H34N2O4.C26H32N2O5.C25H32N6O2.C23H30N8O2.C23H29N7O2/c1-17-5-8-23(18(17)2)29-14-11-27(26(29)32)9-4-12-28(13-10-27)15-24(30)20-6-7-21-22(19(20)3)16-33-25(21)31;1-16-4-7-22(17(16)2)28-12-13-33-26(25(28)31)8-10-27(11-9-26)14-23(29)19-5-6-20-21(18(19)3)15-32-24(20)30;1-18-4-5-20(14-18)30-11-3-8-25(24(30)33)9-12-29(13-10-25)16-23(32)22-7-6-21(15-19(22)2)31-17-26-27-28-31;1-16-4-6-19(17(16)2)30-13-10-23(22(30)33)8-3-11-29(12-9-23)14-20(32)18-5-7-21(26-25-18)31-15-24-27-28-31;1-17-3-4-18(13-17)29-10-2-7-23(22(29)32)8-11-28(12-9-23)15-21(31)20-6-5-19(14-24-20)30-16-25-26-27-30/h6-7,24,30H,1,4-5,8-16H2,2-3H3;5-6,23,29H,1,4,7-15H2,2-3H3;6-7,14-15,17,23,32H,1,3-5,8-13,16H2,2H3;5,7,15,20,32H,1,3-4,6,8-14H2,2H3;5-6,13-14,16,21,31H,1-4,7-12,15H2/t24-,27?;23-;;;/m00.../s1.
What are the key properties of 9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-4-(2-methyl-3-methylidenecyclopenten-1-yl)-1-oxa-4,9-diazaspiro[5.5]undecan-5-one;9-[2-hydroxy-2-[2-methyl-4-(tetrazol-1-yl)phenyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one;9-[2-hydroxy-2-[6-(tetrazol-1-yl)pyridazin-3-yl]ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[2-hydroxy-2-[5-(tetrazol-1-yl)-2-pyridinyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one?
9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-4-(2-methyl-3-methylidenecyclopenten-1-yl)-1-oxa-4,9-diazaspiro[5.5]undecan-5-one;9-[2-hydroxy-2-[2-methyl-4-(tetrazol-1-yl)phenyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one;9-[2-hydroxy-2-[6-(tetrazol-1-yl)pyridazin-3-yl]ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[2-hydroxy-2-[5-(tetrazol-1-yl)-2-pyridinyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one has a molecular weight of 2237.78 g/mol, XLogP of 13.83, 23 rotatable bonds, 5 hydrogen bond donors, and 35 hydrogen bond acceptors.
Where does this data come from?
All data for 9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]-4-(2-methyl-3-methylidenecyclopenten-1-yl)-1-oxa-4,9-diazaspiro[5.5]undecan-5-one;9-[2-hydroxy-2-[2-methyl-4-(tetrazol-1-yl)phenyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one;9-[2-hydroxy-2-[6-(tetrazol-1-yl)pyridazin-3-yl]ethyl]-2-(2-methyl-3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[4.6]undecan-1-one;9-[2-hydroxy-2-[5-(tetrazol-1-yl)-2-pyridinyl]ethyl]-2-(3-methylidenecyclopenten-1-yl)-2,9-diazaspiro[5.5]undecan-1-one is sourced from PubChem (CID 158348185), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).